Assessment of cardiac ischaemia and viability: role of cardiovascular magnetic resonance REVIEW Imaging
... SPECT (Figure 3). This superiority was also shown for multivessel disease CAD. Of note, SPECT performance in the MR-IMPACT was also well comparable with the results of earlier multicentre SPECT studies, which used conventional X-ray coronary angiography as the standard of references reporting sensit ...
... SPECT (Figure 3). This superiority was also shown for multivessel disease CAD. Of note, SPECT performance in the MR-IMPACT was also well comparable with the results of earlier multicentre SPECT studies, which used conventional X-ray coronary angiography as the standard of references reporting sensit ...
The Management of Cocaine Associated Myocardial Ischemia
... several important ways from that of patients with the usual type of myocardial ischemia. Treatment recommendations based on the pathophysiology of cocaineassociated myocardial ischemia must take into account cocaine’s toxic effects on the central nervous system and other vital organs. For example, a ...
... several important ways from that of patients with the usual type of myocardial ischemia. Treatment recommendations based on the pathophysiology of cocaineassociated myocardial ischemia must take into account cocaine’s toxic effects on the central nervous system and other vital organs. For example, a ...
Long-term in vitro study of paclitaxel
... Restenosis is the re-narrowing of a blood vessel which causes a reduction in the diameter of the lumen, consequently restricting blood flow after an intravascular procedure. In-stent restenosis is mainly characterized by an abnormal increase in tissue growth (neointimal hyperplasia) of the tissue co ...
... Restenosis is the re-narrowing of a blood vessel which causes a reduction in the diameter of the lumen, consequently restricting blood flow after an intravascular procedure. In-stent restenosis is mainly characterized by an abnormal increase in tissue growth (neointimal hyperplasia) of the tissue co ...
Bio102_Lab3
... • Use a blunt probe, or your gloved fingers to dissect away tissue. Use the scalpel ONLY for initial cutting. Proceed S-L-O-W-L-Y. • Discard scraps/liquid into the appropriate container • Gloves, paper towels, plastic bags -> regular trash ...
... • Use a blunt probe, or your gloved fingers to dissect away tissue. Use the scalpel ONLY for initial cutting. Proceed S-L-O-W-L-Y. • Discard scraps/liquid into the appropriate container • Gloves, paper towels, plastic bags -> regular trash ...
Coronary Artery Disease - Philippine Heart Association
... is useful or effective although with some conflicting evidence from other trials to trials conducted. The statement “not recommended or contraindicated” means that the procedure is not useful or effective and may be harmful based on sufficient evidence from multiple/single, randomized/non randomized ...
... is useful or effective although with some conflicting evidence from other trials to trials conducted. The statement “not recommended or contraindicated” means that the procedure is not useful or effective and may be harmful based on sufficient evidence from multiple/single, randomized/non randomized ...
Full Prescribing Information
... STEMI undergoing primary PCI. Among patients who experienced an AST, one fatality (0.03%) occurred in an Angiomax treated patient and one fatality (0.03%) in a heparin treated patient. These patients have been managed by Target Vessel Revascularization (TVR). Patients should remain for at least 24 h ...
... STEMI undergoing primary PCI. Among patients who experienced an AST, one fatality (0.03%) occurred in an Angiomax treated patient and one fatality (0.03%) in a heparin treated patient. These patients have been managed by Target Vessel Revascularization (TVR). Patients should remain for at least 24 h ...
Effects of Testosterone on Coronary Vasomotor Regulation in Men
... Plasma testosterone levels in the femoral artery were significantly increased at the greater concentrations of infused testosterone (1166 versus 1464, 1665, 29616, and 35615 nmol/L for baseline versus 10210 to 1027 mol/L testosterone, respectively; P50.40, 0.12, ,0.001, and ,0.001, respectively). Th ...
... Plasma testosterone levels in the femoral artery were significantly increased at the greater concentrations of infused testosterone (1166 versus 1464, 1665, 29616, and 35615 nmol/L for baseline versus 10210 to 1027 mol/L testosterone, respectively; P50.40, 0.12, ,0.001, and ,0.001, respectively). Th ...
Response of Right Ventricular Ejection Fraction to Upright Bicycle
... artery disease, 26 were male and six female; their mean age was 52 years (range 33-66 years). Within 2 months of their exercise radionuclide study, all patients with coronary artery disease underwent selective coronary angiography in multiple views. Patients were clinically stable, without any sympt ...
... artery disease, 26 were male and six female; their mean age was 52 years (range 33-66 years). Within 2 months of their exercise radionuclide study, all patients with coronary artery disease underwent selective coronary angiography in multiple views. Patients were clinically stable, without any sympt ...
Antiplatelet drugs compared - Consumer Reports Best Buy Drugs
... Aspirin lowers the risk of a repeat attack or stroke by about a third in people who have already had a heart attack or stroke. Put another way, it prevents two to three heart attacks or strokes for every 100 people who take it over a three-year period. As a result, the American Heart Association and ...
... Aspirin lowers the risk of a repeat attack or stroke by about a third in people who have already had a heart attack or stroke. Put another way, it prevents two to three heart attacks or strokes for every 100 people who take it over a three-year period. As a result, the American Heart Association and ...
Antecedent hypertension and myocardial injury in patients with
... CMR imaging for assessment of myocardial salvage, infarct size and microvascular obstruction within 10 days after infarction. Major adverse cardiac events (MACE) were recorded at 12-month follow-up. Results: Antecedent hypertension was present in 540 patients (68 %) and was associated with a signifi ...
... CMR imaging for assessment of myocardial salvage, infarct size and microvascular obstruction within 10 days after infarction. Major adverse cardiac events (MACE) were recorded at 12-month follow-up. Results: Antecedent hypertension was present in 540 patients (68 %) and was associated with a signifi ...
Importance of the Conal Branch of the Right Coronary Artery
... coronary circulation, James (22) noted that the LAD might supply varying degrees of the right ventricular free wall. He also noted that the right paraseptal region was supplied by the first big septal branches of the LAD alone or together with the conal branch of the right coronary artery (RCA) (the ...
... coronary circulation, James (22) noted that the LAD might supply varying degrees of the right ventricular free wall. He also noted that the right paraseptal region was supplied by the first big septal branches of the LAD alone or together with the conal branch of the right coronary artery (RCA) (the ...
Increase of QRS Duration as a Predictor of Impending Ventricular
... myocardial infarction model, previously reported in [14]. The first phase, named Ia phase, occurs from 2 to 10 minutes after the onset of ischemia, whereas the second phase, or Ib phase, appears after an arrhythmia-free interval, between 12 and 30 minutes. Since Ia and Ib phases suggest different me ...
... myocardial infarction model, previously reported in [14]. The first phase, named Ia phase, occurs from 2 to 10 minutes after the onset of ischemia, whereas the second phase, or Ib phase, appears after an arrhythmia-free interval, between 12 and 30 minutes. Since Ia and Ib phases suggest different me ...
The Medical Journal of Australia
... • Antithrombin therapy should be given in combination with PCI or fibrinolytic therapy with fibrin-specific fibrinolytic agents, but antithrombin therapy in conjunction with streptokinase is optional. • It is reasonable to use abciximab with primary PCI, but glycoprotein (GP) IIb/IIIa inhibitors sho ...
... • Antithrombin therapy should be given in combination with PCI or fibrinolytic therapy with fibrin-specific fibrinolytic agents, but antithrombin therapy in conjunction with streptokinase is optional. • It is reasonable to use abciximab with primary PCI, but glycoprotein (GP) IIb/IIIa inhibitors sho ...
Contents - British Cardiovascular Society
... Simulator training sessions in percutaneous coronary intervention will be available for specialist registrars at this year's Annual Scientific Conference. ...
... Simulator training sessions in percutaneous coronary intervention will be available for specialist registrars at this year's Annual Scientific Conference. ...
Guidelines for the management of acute coronary syndromes 2006
... • Antithrombin therapy should be given in combination with PCI or fibrinolytic therapy with fibrin-specific fibrinolytic agents, but antithrombin therapy in conjunction with streptokinase is optional. • It is reasonable to use abciximab with primary PCI, but glycoprotein (GP) IIb/IIIa inhibitors sho ...
... • Antithrombin therapy should be given in combination with PCI or fibrinolytic therapy with fibrin-specific fibrinolytic agents, but antithrombin therapy in conjunction with streptokinase is optional. • It is reasonable to use abciximab with primary PCI, but glycoprotein (GP) IIb/IIIa inhibitors sho ...
Anatomical variations of the coronary arteries: I. The most frequent
... 1983). The bifurcation of the anterior interventricular artery should be distinguished from cases of voluminous diagonal arteries, which course in parallel to the anterior interventricular artery (Figure 7), wrongly described as a bifurcation by some authors (James 1961, Paulin 1964, Baroldi and Sco ...
... 1983). The bifurcation of the anterior interventricular artery should be distinguished from cases of voluminous diagonal arteries, which course in parallel to the anterior interventricular artery (Figure 7), wrongly described as a bifurcation by some authors (James 1961, Paulin 1964, Baroldi and Sco ...
Diagnostic accuracy of myocardial deformation indices for detecting
... Abstract: Background: The prediction of coronary artery disease (CAD) by conventional echocardiographic measurements is principally based on the estimation of ejection fraction and regional wall motion abnormality (RWMA). This study aimed to determine whether strain echocardiography of left ventricl ...
... Abstract: Background: The prediction of coronary artery disease (CAD) by conventional echocardiographic measurements is principally based on the estimation of ejection fraction and regional wall motion abnormality (RWMA). This study aimed to determine whether strain echocardiography of left ventricl ...
Reduce Infarct Size
... • Although national door-to-balloon times have improved significantly for patients undergoing primary PCI for ST-segment elevation myocardial infarction, in-hospital mortality has remained virtually unchanged. • These data suggest that additional strategies are needed to reduce in-hospital mortalit ...
... • Although national door-to-balloon times have improved significantly for patients undergoing primary PCI for ST-segment elevation myocardial infarction, in-hospital mortality has remained virtually unchanged. • These data suggest that additional strategies are needed to reduce in-hospital mortalit ...
Original Article - Arquivos Brasileiros de Cardiologia
... Keywords: Angioplasty Balloon Coronary / adverse effects; Coronary Artery Bypass / adverse effects; Myocardial Revascularization; Coronary Artery Disease / surgery; Risk Assessment; Risk Factors. ...
... Keywords: Angioplasty Balloon Coronary / adverse effects; Coronary Artery Bypass / adverse effects; Myocardial Revascularization; Coronary Artery Disease / surgery; Risk Assessment; Risk Factors. ...
A physiologically representative in vitro model of the coronary
... The validity of this model under low left ventricular pressure conditions was shown in vivo (Krams et al 1989a, 1989b, 1989c). A more extended mechanical model, incorporating the functional relation of active myocardial mechanics, perfusion and across-capillary mass transport, was introduced by Zine ...
... The validity of this model under low left ventricular pressure conditions was shown in vivo (Krams et al 1989a, 1989b, 1989c). A more extended mechanical model, incorporating the functional relation of active myocardial mechanics, perfusion and across-capillary mass transport, was introduced by Zine ...
Sudden Cardiac Death Thirty Years Ago and at Present. The Role of
... ventricular focus, a major pathogenic mechanism triggering VF is autonomic dysbalance (disturbance). This term refers to a wide range of reflex changes in the ratio of sympathetic to vagal ventricular activation over time, occurring immediately after coronary artery occlusion at the onset of acute m ...
... ventricular focus, a major pathogenic mechanism triggering VF is autonomic dysbalance (disturbance). This term refers to a wide range of reflex changes in the ratio of sympathetic to vagal ventricular activation over time, occurring immediately after coronary artery occlusion at the onset of acute m ...
Special PICS Preview Issue North American
... PICS meeting. Indeed, recently certain questions have been raised about the appropriateness of "live case" presentations, and this year, we have invited a cardiologist with extensive experience with the "live case" format, Dr. Martin Leon from Columbia University; we hope to have a lively discussion ...
... PICS meeting. Indeed, recently certain questions have been raised about the appropriateness of "live case" presentations, and this year, we have invited a cardiologist with extensive experience with the "live case" format, Dr. Martin Leon from Columbia University; we hope to have a lively discussion ...
... intervention is rarely necessary to simply lower the risk of surgery unless such intervention is indicated irrespective of the preoperative context. The purpose of preoperative evaluation is not to give medical clearance but rather to perform an evaluation of the patient’s current medical status; ma ...
arterial stiffness and coronary artery disease
... that there is a close link between PP and subsequent cardiovascular events.16 Kim et al.15 studied 1,765 patients with acute ischaemic stroke during a mean follow-up period of 3.3 years and showed an independent association between baPWV and all-cause and vascular death. In a recently published arti ...
... that there is a close link between PP and subsequent cardiovascular events.16 Kim et al.15 studied 1,765 patients with acute ischaemic stroke during a mean follow-up period of 3.3 years and showed an independent association between baPWV and all-cause and vascular death. In a recently published arti ...
cardiogenic shock-management - The Association of Physicians of
... Results from the GUSTO trial15 are similar: Among patients with shock, 11% were in shock on arrival and 89% developed shock after admission.Among patients with myocardial infarction, shock is more likely to develop in those who are elderly, are diabetic, and have anterior infarction.17–21 Patients w ...
... Results from the GUSTO trial15 are similar: Among patients with shock, 11% were in shock on arrival and 89% developed shock after admission.Among patients with myocardial infarction, shock is more likely to develop in those who are elderly, are diabetic, and have anterior infarction.17–21 Patients w ...
Drug-eluting stent
A drug-eluting stent (DES) is a peripheral or coronary stent (a scaffold) placed into narrowed, diseased peripheral or coronary arteries that slowly releases a drug to block cell proliferation. This prevents fibrosis that, together with clots (thrombi), could otherwise block the stented artery, a process called restenosis. The stent is usually placed within the peripheral or coronary artery by an interventional cardiologist or interventional radiologist during an angioplasty procedure.Drug-eluting stents in current clinical use were approved by the FDA after clinical trials showed they were statistically superior to bare-metal stents for the treatment of native coronary artery narrowings, having lower rates of major adverse cardiac events (usually defined as a composite clinical endpoint of death + myocardial infarction + repeat intervention because of restenosis). The first drug-eluting stents to be approved in Europe and the U.S. were coated with paclitaxel or an mTOR inhibitor, such as sirolimus.